Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity. - Wikidata - wikimedia - TriplyDB

Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity.

Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity.

http://www.wikidata.org/entity/Q43859481

about

Drug induced exfoliative dermatitis: state of the art Cytotoxic proteins and therapeutic targets in severe cutaneous adverse reactions Recovered patients with Stevens-Johson syndrome and toxic epidermal necrolysis maintain long-lived IFN-γ and sFasL memory response Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series.Amniotic membrane transplantation as a new therapy for the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis.Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.Severe cutaneous adverse drug reactions.Pathogenesis of drug-induced exanthems.Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma.Acute generalized exanthematous pustulosis: role of cytotoxic T cells in pustule formation.Diagnosis of nonimmediate reactions to beta-lactam antibiotics.Toxic epidermal necrolysis: current evidence, practical management and future directions.Current understanding of delayed anticonvulsant hypersensitivity reactions.Chronic pulmonary complications associated with toxic epidermal necrolysis: report of a severe case with anti-Ro/SS-A and a review of the published work.In vitro tests of T cell-mediated drug hypersensitivity.Immunological aspects of nonimmediate reactions to beta-lactam antibiotics.In vitro diagnosis of T cell-mediated drug allergy.Animal models of toxic epidermal necrolysis.Overview of penicillin allergy.Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases.Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.Contributions of pharmacogenetics and transcriptomics to the understanding of the hypersensitivity drug reactions.Tests for evaluating non-immediate allergic drug reactions.Immunological response in Stevens-Johnson syndrome and toxic epidermal necrolysis.Cellular in vitro diagnosis of adverse drug reactions Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Update.Immunologic Mediators in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.Recent advances in the understanding of severe cutaneous adverse reactions.Prevention of severe cutaneous adverse drug reactions: the emerging value of pharmacogenetic screening A case of drug-induced hypersensitivity syndrome with multiple organ involvement treated with plasma exchange.Cytotoxic mechanisms in different forms of T-cell-mediated drug allergies.Metolazone Associated Stevens Johnson Syndrome-Toxic Epidermal Necrolysis Overlap.Role of effector cells (CCR7(-)CD27(-)) and effector-memory cells (CCR7(-)CD27(+)) in drug-induced maculopapular exanthema.Expression of α-defensin 1-3 in T cells from severe cutaneous drug-induced hypersensitivity reactions.Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.CD8+ T-cell activation by methazolamide causes methazolamide-induced Stevens-Johnson syndrome and toxic epidermal necrolysis.Treatments for Severe Cutaneous Adverse Reactions.Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions.The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China.An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity.

P2860

Q26739886-A720B28C-07FB-4009-B434-52A8CB28EE8F Q28395744-60AF4D24-222B-4558-866D-61FDCD8683BC Q28483831-5D2DFCD8-CADF-4FA3-B0E0-BEA4E9DA83B7 Q33374316-059014D4-4C6E-4D4E-A8F7-C9BEA311D360 Q33786399-B3CECDC5-D887-426B-B241-769F75954691 Q33844415-FC37FB47-D9E6-48F4-8993-C73B39236FB7 Q34525532-849B7FAA-E626-45BD-8959-1F644FB31388 Q34881170-F8B112AC-EA8D-4252-8F34-EDA95FB335F2 Q35004399-655553A8-96C5-4F9E-92C3-52CD271C56EE Q35748154-12F92BB5-DC6E-4972-8B07-C36B7A8EF587 Q35907069-2C65CE77-F417-4AC0-B61A-9C56934D46B4 Q36222123-ACC0229A-3258-4B6E-BDB3-B32FEE880DA4 Q36444480-7A50A1A5-CAE5-4B40-9F08-7EB9832A0198 Q36588321-0AF41E91-CBC8-408D-BF5B-85E6CB2ED52E Q37754599-EE48B815-88FA-4D5F-A437-ABD62F3A6493 Q37786631-6BB70842-3864-41E4-8257-57CB3E722EC5 Q37845431-AC4BCE70-BBBB-4FD2-8EE3-FCA76F9706DF Q37845915-9117F5DC-E096-47BA-9DA4-7E5DE62C0FC0 Q37905733-A226FA62-0F5D-460A-97E9-3C252D6D2922 Q38049184-51F3B08E-6063-4952-84C4-A252F1FF1152 Q38123116-9C3D95F0-A6CE-4A3A-B616-FF83272FFFCF Q38182188-836F903D-7341-47FF-BEA4-830276835929 Q38258564-65F9250C-339B-48B0-A834-B0BCAF909B29 Q38263760-6A98D095-4A87-4815-9871-0A31FA8F5B10 Q38539744-1721FC75-EB7F-42D8-A44F-ABD2510DC651 Q38611191-CF9DD9D6-44D8-4968-8DF9-157522675A26 Q38766822-113819AF-0EF2-48A1-92F4-252A3E4CB8B0 Q38931289-D99EFD39-9955-44C3-94E9-0AEF27670BC0 Q39729427-984F3642-E484-4D03-985E-4F521F098916 Q40497268-2637426B-A6BB-493D-84D2-BFAE657133EE Q40555251-D0942DFF-1BDD-437C-83DD-EE7A4E602C55 Q40571518-C6C71765-4B05-42D5-8F54-9983A7E9D31A Q44114312-BA1EC875-9C19-43D0-BE53-55E3F374EA5B Q46414139-A6D04A4E-42A9-4B80-97EE-F621C90E9B4B Q47571365-A22DDB30-CD3A-4EEF-ABF9-FC45FA509235 Q48124307-D30AA17C-9306-47F9-8389-23AD04CFA9F8 Q49264547-4B274E9E-9A28-4226-97B4-04C77E6EBB80 Q50063459-7DAB0380-99FD-43A8-9092-08920A24FD4D Q52614370-21320F74-F44C-49CC-91A9-471D5061A692 Q52719665-95E8BA6A-225C-4CEF-9471-87F83F84D2BE

P2860

Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity.

http://www.wikidata.org/entity/Q43859481

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Delayed reactions to drugs sho ...... e related to disease severity.

@en

Delayed reactions to drugs sho ...... e related to disease severity.

@nl

type

label

Delayed reactions to drugs sho ...... e related to disease severity.

@en

Delayed reactions to drugs sho ...... e related to disease severity.

@nl

prefLabel

Delayed reactions to drugs sho ...... e related to disease severity.

@en

Delayed reactions to drugs sho ...... e related to disease severity.

@nl

P1433

Q43859481-F3518F34-FF97-4898-81F2-AAEC9D0CFE8F

P1476

Q43859481-032EC226-0E5E-408A-B8CE-C2FE1EE0A4C9

P2093

Q43859481-28D215B1-FFF8-4EBD-8B56-7A377F324242

Q43859481-30974E94-80B7-4C8D-9CE0-E648CCA6C6C0

Q43859481-43CA8235-E7FC-4B66-A48F-67EF8B9C15B1

Q43859481-66F04BA6-5D03-40BF-9D3F-64C90F3F7611

Q43859481-74FF44B4-D814-4096-BFA8-62C429F99B05

Q43859481-8E722964-82AA-47FB-995D-1C66D398F496

Q43859481-B0F76EEC-4AD2-406F-BD66-CDBDE7A7B589

Q43859481-E904CD39-6FAB-4692-B64B-2653869A2052

Q43859481-F4C69B07-73C2-4255-A208-9D328C10D6C2

P304

Q43859481-9CCAA3BE-6700-4DFC-A335-60DE639BB109

P31

Q43859481-CAB1B2EC-B60F-4A14-96AD-2047FD52F473

P356

Q43859481-AC33984F-6517-4BDA-A20E-B4A2FA581FAB

P407

Q43859481-B4B4C22A-0EF7-48AF-AC06-7D25A50F14AE

P433

Q43859481-902DECEF-0F1D-4D38-AF65-2B01C031A95B

P478

Q43859481-31FD4473-4D01-46A7-9913-84C33CA94689

P50

Q43859481-74987505-5403-4F9C-B683-BE5B015F429B

P577

Q43859481-CB03B9D7-E7B7-4908-A6C5-D24694FC9BB3

P698

Q43859481-DC198DC2-208A-4659-84B7-72B24A4608D6

P356

MAI.2002.120563

P1433

The Journal of Allergy and Clinical Immunology

P1476

Delayed reactions to drugs sho ...... e related to disease severity.

@en

P2093

Antonia Padial

http://www.w3.org/2001/XMLSchema#string

Antonino Romano

http://www.w3.org/2001/XMLSchema#string

Carlos Juarez

http://www.w3.org/2001/XMLSchema#string

Cristobalina Mayorga

http://www.w3.org/2001/XMLSchema#string

Elena Sanchez

http://www.w3.org/2001/XMLSchema#string

Javier Alvarez

http://www.w3.org/2001/XMLSchema#string

Laura Leyva

http://www.w3.org/2001/XMLSchema#string

Miguel Blanca

http://www.w3.org/2001/XMLSchema#string

Sinforiano J Posadas

http://www.w3.org/2001/XMLSchema#string

P304

155-161

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1067/MAI.2002.120563

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11799383

http://www.w3.org/2001/XMLSchema#string